Navigation Links
MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results
Date:5/4/2012

MOUNTAIN VIEW, Calif., May 4, 2012 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced financial results for the first quarter ended March 31, 2012.

The net loss for the first quarter ended March 31, 2012 was $17.8 million, compared to a net loss of $16.0 million during the same period in 2011. The net loss for the first quarter ended March 31, 2012 included a one-time expense of $2.8 million for the purchase of a data package relating to the propellant used for LEVADEX. MAP Pharmaceuticals had $79.0 million in cash and cash equivalents as of March 31, 2012, compared to $98.8 million as of December 31, 2011.

"Following receipt of the Complete Response letter from the FDA on March 26 for our LEVADEX NDA submission, we will meet with the FDA in the second quarter of this year and we look forward to gaining clarity around the issues raised in the letter," said Timothy S. Nelson, president and chief executive officer of MAP Pharmaceuticals. "We believe that LEVADEX has the potential to be an important treatment for many of the 30 million Americans who suffer from migraine, and we will continue to closely collaborate with the FDA to address the issues raised in the Complete Response letter as quickly as possible."

Revenues for the first quarter ended March 31, 2012 were $1.0 million, compared to $0.6 million for the same period in 2011. The revenues for both periods were due to amortization of a $60.0 million nonrefundable upfront cash payment received in February 2011, pursuant to a collaboration agreement with Allergan, Inc. entered into in January 2011.

Research and development (R&D) expenses for the first quarter ended March 31, 2012 were $11.0 million, compared to $11.6 million for the same period in 2011. The decrease in R&D expenses for the three months ended March 31, 2012 was caused primarily by a decrease in expen
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
2. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
3. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
4. Savient Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
5. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
6. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
7. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
8. Optimer Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
9. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
10. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
11. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014 /CNW/ - ... being recalled after Health Canada tests confirmed it contains ... risks (beta-methylphenethylamine and phenylpropylmethylamine). The distributor, Empire Health Distribution ... the product from retail stores across Canada ... purposes, including for weight loss and increased energy. ...
(Date:12/24/2014)... Mexico , Dec. 24, 2014  Novastem, ... of its first patient in its study for ... the American Stroke Association, ischemic strokes account for ... to enroll qualified patients in the study, entitled ... Administration of Allogeneic Mesenchymal Stem Cells and Intrathecal ...
(Date:12/24/2014)... DUBLIN , Dec. 24, 2014  Actavis ... that the Company has received a complete response ... (FDA) for its New Drug Application (NDA) for ... for the treatment of hypertension.   Photo ... we are disappointed in the receipt of a ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4
... EntreMed, Inc. (Nasdaq: ENMD ), ... treatment of cancer, today reported results for the ... (Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO) ... for the third quarter of 2010 of ($2.1 ...
... Nile Therapeutics, Inc. (Nasdaq: NLTX ), a ... for cardiovascular disease, today announced its third quarter financial results ... ended September 30, 2010, Nile reported a net loss of ... net loss of approximately $2.0 million, or $0.08 per share, ...
Cached Medicine Technology:EntreMed Reports Third Quarter 2010 Financial Results 2EntreMed Reports Third Quarter 2010 Financial Results 3EntreMed Reports Third Quarter 2010 Financial Results 4Nile Therapeutics Reports 2010 Third Quarter Financial Results 2Nile Therapeutics Reports 2010 Third Quarter Financial Results 3Nile Therapeutics Reports 2010 Third Quarter Financial Results 4
(Date:12/24/2014)... Dennis Thompson HealthDay Reporter TUESDAY, ... have abstained from sex for one year will be allowed to ... that would reverse a 31-year ban on donations from men who ... announced Tuesday its intention to release a new draft guidance in ... from gay men. The FDA is changing its policy based ...
(Date:12/24/2014)... (HealthDay News) -- Researchers say they have used human ... eggs and sperm. While this had already been ... time that these types of cells -- called primordial ... stem cells, according to the team at the University ... germ cells is one of the earliest events during ...
(Date:12/24/2014)... December 24, 2014 For chic ladies, new ... As a part of their Holiday Wish List, Angeldress.co.uk ... as perfect ways to accent ladies’ holiday wardrobe by launching ... should be all over the discount of 80% off, like ... ready to ship. The company’s chic wedding dresses are among ...
(Date:12/24/2014)... There’s a lot going on with The ... now in control of the Senate as well as the ... Act. A lawsuit has been brought against President Obama by ... the ACA have resulted in changes to the law without ... will take place to weigh the validity of subsidies provided ...
(Date:12/24/2014)... December 24, 2014 Attorneys handling talcum ... an update to their website, the Talcum Powder ... between talcum powder class action lawsuits and ovarian cancer ... and ovarian cancer updates at their website, which serves ... for ovarian cancer claims are not the same as ...
Breaking Medicine News(10 mins):Health News:FDA to Lift Ban on Blood Donations by Gay Men 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 3Health News:Angeldress.co.uk Starts Its Big Sales by Offering Various Kinds of Cheap Clothes and Fashion Accessories 2Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 2Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 3Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 2Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 3Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 4
... , , PITTSBURGH , ... grand opening of the first Visionworks® location in western PA. ... thousand private label and designer frames along with contact lenses ... eye care services, Visionworks will debut its first local store ...
... ... who has become an Internet sensation. , ... (PRWEB) February 5, 2010 -- An English ad-man,s overnight verbal outbursts are an ... tips web site SleepBetter.org , says sleep talking is actually quite common and may have ...
... , , LAKE FOREST, Ill. ... Trustmark Mutual Holding Company and Health Fitness Corporation (NYSE AMEX: ... Commission has granted early termination of the waiting period under ... acquisition of HealthFitness. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20090122/CG61641LOGO ) , ...
... ... lion that was first spotted at San Francisco,s famed PIER 39 docks, was successfully rescued, ... Despite rainy skies, a crowd assembled at Rodeo Beach in the Marin Headlands, Sausalito, ... , ...
... , Feb. 5 Food 4 Less Stores is ... hospitals in the communities its stores serve in Southern California ... area. In addition, the supermarket chain,s Foods Co Division is collecting ... , Customers and team members can support their local children,s hospital ...
... TROY, Mich. , Feb. 5 CareTech Solutions ... and services company serving U.S. hospitals and health systems, announced ... newly formed position of vice president, Marketing, Communications and Government ... delighted to have Colleen join the CareTech Solutions team," said ...
Cached Medicine News:Health News:Visionworks(R) Brings High Quality Eye Care & Eye Wear to Cranberry 2Health News:Visionworks(R) Brings High Quality Eye Care & Eye Wear to Cranberry 3Health News:Sleep Expert on "Sleep Talkin' Man:" It Could Happen To Anyone 2Health News:Sleep Expert on "Sleep Talkin' Man:" It Could Happen To Anyone 3Health News:Trustmark and HealthFitness Announce Early Termination of Hart-Scott-Rodino Waiting Period 2Health News:Trustmark and HealthFitness Announce Early Termination of Hart-Scott-Rodino Waiting Period 3Health News:Trustmark and HealthFitness Announce Early Termination of Hart-Scott-Rodino Waiting Period 4Health News:Entangled in Fishing Line then Rescued by The Marine Mammal Center - a Sea Lion Goes Back to the Ocean 2Health News:Entangled in Fishing Line then Rescued by The Marine Mammal Center - a Sea Lion Goes Back to the Ocean 3Health News:Entangled in Fishing Line then Rescued by The Marine Mammal Center - a Sea Lion Goes Back to the Ocean 4Health News:Food 4 Less Charitable Campaign to Benefit Children's Hospitals 2Health News:CareTech Solutions Names Colleen M. Hanley Vice President of Marketing, Communications and Government Affairs 2Health News:CareTech Solutions Names Colleen M. Hanley Vice President of Marketing, Communications and Government Affairs 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: